Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Increlex 10 mg/ml solution for injection {equilateral_black_triangle}

Active Ingredient:
mecasermin
Company:  
Esteve Pharmaceuticals (formerly Intrapharm Laboratories) See contact details
ATC code: 
H01AC03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Increlex 10 mg/ml solution for injection Dosing Guide

This is a doising guide for Increlex 10 mg/ml solution for injection

{pdf_link}

Increlex 10 mg/ml solution for injection Hypoglycaemia Leaflet

This leaflet provides information for parents, caregivers or for patients, about hypoglycaemia and what to do if it occurs.

{pdf_link}

Increlex 10 mg/ml solution for injection Patient Educational Information

Patient Educational Information about Severe Primary IGF-1 Deficiency and how Increlex® can help.

{pdf_link}

Physician information about Increlex®

{healthcare_pro_orange} For Healthcare Professionals

This document contains information about Increlex® for physicians.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Esteve Pharmaceuticals (formerly Intrapharm Laboratories)
Company image
Address
The Courtyard Barns, Choke Lane, Cookham Dean, Maidenhead, Berkshire, SL6 6PT
E-mail
[email protected]
Telephone
+44 (0)1628 771 800
Medical Information Direct Line
+44 (0)330 1359 437
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)1908 533 370